In just a few years, brand-name injectable drugs such as Ozempic, Wegovy, Mounjaro and Zepbound have rocketed to fame as ...

StudyFinds' Dr. Faith Coleman looks at the common mistakes patients make using GLP-1 agonists like Ozempic and Wegovy.

Investors in weight-loss drug companies like Novo Nordisk and Eli Lilly face concerns over side effects and market ...

The Biden administration's proposed Medicare $2 Drug List Model aims to provide low-cost generic drugs for seniors and people ...

A CNBC investigation into counterfeit weight-loss drugs revealed an international illegal marketplace where criminals either alter the drugs or ship the real product from overseas.

Micro-cap stocks are typically categorized as companies with market capitalizations between $50 million and $300 million. However, it's not a hard-and-fast rule. Many small stocks can fluctuate ...

Some patients fear that they’ll lose access to tirzepatide because the US Food and Drug Administration determined that a ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Eli Lilly said Wednesday it will invest $4.5 billion to build an advanced pharmaceutical drug manufacturing and development facility in Lebanon, Indiana expected to open in late 2027. Fatty liver ...

American adults prefer dietary change as a weight loss method, over injectable weight loss drugs such as Ozempic, a survey says.

A highly effective class of weight loss drug has taken the world by storm, as medications like Ozempic, Wegovy, and Zepbound ...

Starboard has a roughly $1 billion stake in the drugmaker and approached former Pfizer CEO Ian Read and ex-CFO Frank D'Amelio ...